Embarc

Murphy Canyon Acquisition Corp.

Merged
CIK: 1896212•Ticker: MURF
Successfully merged with Conduit Pharmaceuticals • Now trading as

SPAC Overview

$115M
IPO Size
Completed
Current Status
2022
IPO Year

Timeline Progress

Investment Focus

Real Estate, PropTech, Homebuilding, Insurance, Financial Services

SPAC Team

Sponsors

Murphy Canyon Acquisition SponsorMurphy Canyon Management Group

Leadership

Jack H. Heilbron
Adam Sragovicz
Chief Financial Officer, Treasurer, and Director
Jack K. Heilbron
Chief Executive Officer, President, and Chairman
Ed Bentzen
Chief Accounting Officer
Francis Knuettel II
Director
Chele Chiavacci Farley
Director
Richard E. Feinberg
Director

Key Information

February 4, 2022
September 20, 2023
Conduit Pharmaceuticals
MURFU

External Resources

SEC Filings
View Detailed Analysis